TABLE 2.
Peptide and combination agent | Mean (range) FIC index
|
||||||
---|---|---|---|---|---|---|---|
Staphylococcus aureus | Enterococcus faecalis | Rhodococcus equi | Streptococcus pyogenes | ||||
Pal-Lys-Lys-NH2 | |||||||
Imipenem | 0.46 (0.31-0.75)a | 0.31 (0.19-0.50)a | 0.31 (0.19-0.50)a | 0.46 (0.31-0.75)a | |||
Doxycycline | 1.17 (0.75-2.00)b | 1.83 (1.50-2.00)b | 1.83 (1.50-2.00)b | 1.46 (1.00-2.00)b | |||
Clarithromycin | 1.50 (1.00-2.00)b | 1.17 (0.75-2.00)b | 1.46 (1.00-2.00)b | 1.46 (1.00-2.00)b | |||
Linezolid | 1.50 (1.00-2.00)b | 1.46 (1.25-2.00)b | 1.17 (0.75-2.00)b | 1.50 (1.000-2.00)b | |||
Vancomycin | 0.46 (0.31-0.75)a | 0.31 (0.19-0.50)a | 0.39 (0.31-0.50)a | 0.39 (0.31-0.50)a | |||
Amoxicillin | 0.31 (0.19-0.50)a | 0.39 (0.31-0.50)a | 0.31 (0.19-0.50)a | 0.39 (0.31-0.50)a | |||
Pal-Lys-Lys |
|
||||||
Imipenem | 0.31 (0.18-0.50)a | 0.31 (0.19-0.50)a | 0.39 (0.31-0.50)a | 0.31 (0.19-0.50)a | |||
Doxycycline | 1.50 (1.00-2.00)b | 1.83 (1.50-2.00)b | 1.17 (1.00-1.50)b | 1.50 (1.00-2.00)b | |||
Clarithromycin | 1.17 (0.75-2.00)b | 1.83 (1.50-2.00)b | 1.46 (1.00-2.00)b | 1.46 (1.00-2.00)b | |||
Linezolid | 0.91 (0.750-1.25)b | 1.17 (1.00-1.50)b | 0.92 (0.75-1.25)b | 1.29 (0.75-2.00)b | |||
Vancomycin | 0.46 (0.31-0.75)a | 0.39 (0.31-0.50)a | 0.46 (0.31-0.75)a | 0.46 (0.31-0.75)a | |||
Amoxicillin | 0.31 (0.19-0.50)a | 0.39 (0.31-0.50)a | 0.31 (0.19-0.50)a | 0.31 (0.19-0.50)a |
Synergy.
Indifference.
The ranges of concentrations tested were 0.125 to 64 mg/liter for lipopeptides and 0.25 to 256 mg/liter for the other antimicrobial agents. Six strains for each genus were tested. Antagonism was absent for all combinations tested.